Feinstein Institute

ALZ: Genetic variants can run, but they can’t hide

The Feinstein Institute for Medical Research is targeting genetic risk factors behind Alzheimer’s disease, the first of many steps toward new potential treatments. Feinstein Institute assistant professor Yun Freudenberg-Hua has been awarded a five-year, $600,000 grant by the National Institutes of Health’s National Institute on Aging, supporting her mission to better understand the genetic causes of a disease that inflicts an estimated 5.5 million Americans. Ultimately, the doctor and her staff hope to develop new…


Feinstein, Hofstra concussion study exposes a nerve

By GREGORY ZELLER // With concussions and other traumatic brain injuries continuing to make headlines on and off the playing field, Long Island researchers may be closing in on a unique treatment method. Scientists at the Feinstein Institute for Medical Research and the Hofstra Northwell School of Medicine have published the results of a nerve-stimulation study with broad-ranging implications for many neurological conditions, including severe TBIs. Published online by the international science journal Nature, the…


An SBU sweep in Bioscience Hub’s latest round

By GREGORY ZELLER // Five research projects targeting advanced medical-imaging applications, computer-based drug discoveries and a range of new pharmaceutical treatments will be backed by the Long Island Bioscience Hub. The Center for Biotechnology at Stony Brook University, on behalf of the LIBH, announced Tuesday the fourth funding round of the Hub’s technology-commercialization initiative. This time around, a total of $400,000 has been earmarked for two “feasibility” and three “proof of concept” awards, each backing biomedical…


Where the girls are: At Feinstein, kicking butt

By GREGORY ZELLER // Reinforcing science’s gender-neutral nature, the Feinstein Institute for Medical Research honored several of its top female scientists Monday during its yearly Advancing Women in Science and Medicine awards. The sixth-annual AWSM luncheon – yes, it’s pronounced “awesome” – dished out more than $225,000 in awards to both support and celebrate the achievements of women engaged in scientific pursuits. Jennifer Ashton, the chief women’s health correspondent for ABC News and the “Good…


Big investment, tiny particles and a giant leap for BNL

BY MICHAEL FAIRLIE // Brookhaven National Laboratory is stepping up its electromicroscopy game, in a big way. The fiscal year 2017 New York State budget includes $15 million for the Upton laboratory to purchase and install a cryo-electron microscope, which will work in tandem with the National Synchrotron Light Source II, the world’s brightest synchrotron light source. The Cryo-EM will be the backbone of BNL’s new Long Island Facility for Electromicroscopy, a national user facility…


‘Young’ Feinstein scientist nabs national autism award

Efforts to determine the elusive causes of autism have earned national accolades for an up-and-coming Feinstein Institute scientist. Lior Brimberg, an assistant research professor in the Center for Autoimmune and Musculoskeletal Disease at the Feinstein Institute for Medical Research in Manhasset, has received the Young Investigator Award from the International Society of Autism Research for “her innovative work in helping to identify the causes of autism,” according to the institute, the research-and-development division of the…


Feinstein, TheraSource target sepsis, with NIH’s help

By GREGORY ZELLER // With a little help from the besieged National Institutes of Health, a pillar of Long Island-based scientific research and one of its shining biotech spinoffs are taking the fight to a modern-medicine scourge responsible for some 500,000 U.S. deaths each year. The Feinstein Institute for Medical Research, the R&D division of the Northwell Health system, and Manhasset-based TheraSource LLC, a circa-2004 biopharma spun out of the Feinstein Institute, announced this week…


Feinstein researchers eye brain-tumor breakthrough

A common medication used to treat parasitic infections could leapfrog to the top of medical science’s brain-cancer arsenal. Pure scientific research funded by federal grants has led to this potential oncological breakthrough by the Feinstein Institute for Medical Research, the research-and-development division of the Northwell Health system. Marc Symons, a professor in the Feinstein Institute’s Karches Center for Oncology Research, is exploring the use of mebendazole – a medication commonly used to treat pinworms –…


Donald Trump, Long Island and the war on science

By GREGORY ZELLER // There’s worry, if not panic, among the scientists at the heart of the Long Island innovation economy. Certainly, none are surprised that President Donald Trump, in his first proposed budget, took square aim at the federal funding that is the lifeblood of the nation’s scientific research programs. This is, after all, a president who calls climate change a hoax, champions coal and selected a former ExxonMobil CEO as his secretary of…


In e-health, one app to rule them all

By GREGORY ZELLER // With thousands of healthcare-related software programs and mobile apps now available to patients and providers, creating an industry-wide standard to evaluate their performances has been a virtually impossible mission – until now. An innovative professor at the Feinstein Institute for Medical Research is developing a tool that can evaluate the quality and “therapeutic potential” of computer- and mobile-based e-health applications – the first-ever digital resource designed specifically to compare and rate…


Researchers zoom in on schizophrenia biomarkers

A Feinstein Institute for Medical Research scientist will focus next-level imaging techniques on schizophrenia and other brain disorders, thanks to a hefty federal grant. Research scientist Anil Malhotra – a professor in the Feinstein Institute’s Center for Psychiatric Neuroscience and the Hofstra Northwell School of Medicine’s Department of Molecular Medicine – has been awarded a five-year, $3 million R01 grant from the National Institutes of Health to identify biomarkers specific to schizophrenia and treatment-resistant psychosis. The biomarkers…


Northwell, drug-maker ink bioelectronics partnership

By GREGORY ZELLER // Bioelectronic medicine has taken another forward leap, thanks to the Feinstein Institute for Medical Research’s latest professional alliance. The research-and-development arm of the Northwell Health system announced Thursday that it will apply its cutting-edge bioelectronics and cell-therapy technologies to cardiology and hypertension cases through a new “strategic partnership” with United Therapeutics Corp. Financial terms were not disclosed, but United Therapeutics will “fund Northwell’s efforts in four research-and-development tracks” while ushering new…


Rockefeller researcher nabs Feinstein’s molecular prize

Advanced molecular-genetics studies have earned a Rockefeller University researcher accolades from the Feinstein Institute for Medical Research, and a fat check. While Feinstein Institute scientists are often the ones collecting the research prizes, this time the institute is dishing it out, naming Jeffrey Ravetch – head of the Leonard Wagner Laboratory of Molecular Genetics and Immunology at The Rockefeller University in New York City – the recipient of the fifth-annual Ross Prize in Molecular Medicine….


Energy, life sciences pace 2017 Innovation Boot Camp

By GREGORY ZELLER // Several innovators sitting on potentially game-changing technologies have been selected for one of Long Island’s most effective commercialization crash courses. Stony Brook University has announced the eight teams participating in the 10th annual Innovation Boot Camp, a three-day exercise that surrounds researchers, engineers and other rookie entrepreneurs with customized teams of commercialization experts to help them explore the rigors of business development. This year’s boot campers represent a diverse selection of…


GE brings good things to bioelectronics research

By GREGORY ZELLER // General Electric is giving the Feinstein Institute for Medical Research a bioelectronic jolt. The Feinstein Institute, R&D mecca of the Northwell Health system, announced a new “strategic alliance” Tuesday with GE Ventures, the multinational conglomerate’s New Jersey-based business-licensing and equity arm. While no financial terms were disclosed, Northwell Health did note an “investment” that will help the Feinstein Institute’s evolving Center for Bioelectronic Medicine “continue its work in discovering, developing and…